HDIM
NEUP

Hanson & Doremus Investment Management’s Neuphoria Therapeutics NEUP Stock Holding History

Hanson & Doremus Investment Management’s Portfolio NEUP Stock Details NEUP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed – – 500
2024
Q4 		$0 Buy
+1
New +$4 ﹤0.01% 464

Other funds holding NEUP

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $2.12B AUM 24.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hanson & Doremus Investment Management's NEUP Position: Q1 2025 in Review

Hanson & Doremus Investment Management sold out of Neuphoria Therapeutics (NEUP) in Q1 2025, closing a stake of 1 share.

Hanson & Doremus Investment Management first reported a position in NEUP in Q4 2024 and held it in 1 quarter. The position peaked at $0 in Q4 2024. 7 funds tracked by Wall St. Rank hold NEUP as of Q1 2025.

  • Hanson & Doremus Investment Management reported no remaining Neuphoria Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 1 Neuphoria Therapeutics share in Q1 2025.
  • Hanson & Doremus Investment Management first reported a position in Neuphoria Therapeutics in Q4 2024 and held it in 1 quarter.
  • Hanson & Doremus Investment Management's Neuphoria Therapeutics position peaked at $0 in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q1 2025.

Based on Hanson & Doremus Investment Management's 13F filing for Q1 2025, filed 17 Apr 2025.